z-logo
open-access-imgOpen Access
Defining the clinical need for rare red blood cells
Author(s) -
Yahalom V.
Publication year - 2013
Publication title -
isbt science series
Language(s) - English
Resource type - Journals
eISSN - 1751-2824
pISSN - 1751-2816
DOI - 10.1111/voxs.12005
Subject(s) - medicine , intensive care medicine , red blood cell , antibody , blood transfusion , red blood cell transfusion , clinical trial , immunology
Transfusion support of patients with antibodies against high frequency ( HF ) antigens or a combination of antibodies that is rare is challenging and requires multidisciplinary cooperation. The treating physician should decide if there is a definitive clinical need for red blood cell ( RBC ) transfusion for the specific patient. According to recent clinical trials RBC transfusion is usually not indicated if the patient is haemodynamically stable and the haemoglobin (Hb) is higher than 7 g/dl. Alternative strategies for patient support might be required if rare blood is unavailable or while awaiting rare RBC unit arrival from national or international sources.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here